Mario Giordano

Dr. Mario Giordano

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Kidney International
Verified
Journal Article
Closed access
VPViviana Palazzo
Viviana Palazzo
APAldesia Provenzano
Aldesia Provenzano
FBFrancesca Becherucci
Francesca Becherucci
GSGiulia Sansavini
Giulia Sansavini
BMBenedetta Mazzinghi
Benedetta Mazzinghi
SGSabrina Giglio
Sabrina Giglio

27 January 2004 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
RBRosa Bellantuono
Rosa Bellantuono
GMGiovanni Messina
Giovanni Messina
ACAngela D. Caringella
Angela D. Caringella
TPTommaso De Palo
Tommaso De Palo
MGMario Giordano
Mario Giordano
VCVincenzo Colella
Vincenzo Colella

22 March 2007 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
MSMaria Esposito Salsano
Maria Esposito Salsano
LGLuisa Graziano
Luisa Graziano
ILIlaria Luongo
Ilaria Luongo
PPPaola Pilla
Paola Pilla
MGMario Giordano
Mario Giordano
GLGiuliana Lama
Giuliana Lama

26 May 2016 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
SMSalvatore Melchionda
Salvatore Melchionda
TPTeresa Palladino
Teresa Palladino
SCStefano Castellana
Stefano Castellana
MGMario Giordano
Mario Giordano
EBElisa Benetti
Elisa Benetti
LBLuigi Bisceglia
Luigi Bisceglia

22 September 2016 in Eurosurveillance
Verified
Journal Article
Open access
CGCinzia Germinario
Cinzia Germinario
ACAlfredo Caprioli
Alfredo Caprioli
MGMario Giordano
Mario Giordano
Maria ChironnaMaria Chironna
Maria Chironna
MGMaria Serena Gallone
Maria Serena Gallone
OTon behalf of all participants of the Outbreak investigation team
on behalf of all participants of the Outbreak investigation team
In summer 2013, an excess of paediatric cases of haemolytic uraemic syndrome (HUS) in a southern region of Italy prompted the investigation of a community-wide outbreak of Shiga toxin 2-producing Escherichia coli (STEC) O26:H11 infections. Case finding was based on testing patients with HUS or bloody diarrhoea for STEC infection by microbiological and serological methods. A case–control study was conducted to identify the source of the outbreak. STEC O26 infection was identified in 20 children (median age 17 months) with HUS, two of whom reported severe neurological sequelae. No cases in adults were detected. Molecular typing showed that two distinct STEC O26:H11 strains were involved. The case–control study showed an association between STEC O26 infection and consumption of dairy products from two local plants, but not with specific ready-to-eat products. E.coli O26:H11 strains lacking the stx genes were isolated from bulk milk and curd samples, but their PFGE profiles did not match those of the outbreak isolates. This outbreak supports the view that infections with Stx2-producing E. coli O26 in children have a high probability of progressing to HUS and represent an emerging public health problem in Europe.

3 March 2014 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
LSLuisa Santangelo
Luisa Santangelo
MGMaddalena Gigante
Maddalena Gigante
GNGIUSEPPE STEFANO NETTI
GIUSEPPE STEFANO NETTI
SDSterpeta Diella
Sterpeta Diella
FPFlora Puteo
Flora Puteo
LGLoreto Gesualdo
Loreto Gesualdo
Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1.